ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Delta-Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-7M17378
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Delta Valerolactone Market Research Report 2024
BUY CHAPTERS

Global Delta-Valerolactone Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7M17378
Report
November 2025
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CU CHEMIE UETIKON GMBH
Synova Chemicals
Aether Industries
Nem
ZHEJIANG BOADGE CHEMICAL

Delta-Valerolactone Market

The global Delta-Valerolactone market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Delta-valerolactone (CAS:542-28-9) is an intermediate for organic synthesis and pharmaceutical research and development. It can be used in laboratory organic research and development processes and chemical and pharmaceutical synthesis processes.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Delta-Valerolactone leading manufacturers including BASF, UBE Industries, CU Chemie Uetikon GmbH, Synova Chemicals, Aether Industries, NEM, Zhejiang Boadge Chemical, etc., dominate supply; the top five capture approximately % of global revenue, with BASF leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Delta-Valerolactone market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Delta-Valerolactone Market Report

Report Metric Details
Report Name Delta-Valerolactone Market
Segment by Type
  • Purity 99%
  • Purity 98%
  • Others
Segment by Application
  • Pharmaceutical
  • Pesticide
  • Fiber
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
  • India
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BASF, UBE Industries, CU Chemie Uetikon GmbH, Synova Chemicals, Aether Industries, NEM, Zhejiang Boadge Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Delta-Valerolactone study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Delta-Valerolactone Market report?

Ans: The main players in the Delta-Valerolactone Market are BASF, UBE Industries, CU Chemie Uetikon GmbH, Synova Chemicals, Aether Industries, NEM, Zhejiang Boadge Chemical

What are the Application segmentation covered in the Delta-Valerolactone Market report?

Ans: The Applications covered in the Delta-Valerolactone Market report are Pharmaceutical, Pesticide, Fiber, Others

What are the Type segmentation covered in the Delta-Valerolactone Market report?

Ans: The Types covered in the Delta-Valerolactone Market report are Purity 99%, Purity 98%, Others

1 Study Coverage
1.1 Introduction to Delta-Valerolactone: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Delta-Valerolactone Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 99%
1.2.3 Purity 98%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Delta-Valerolactone Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Pesticide
1.3.4 Fiber
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Delta-Valerolactone Revenue Estimates and Forecasts 2020-2031
2.2 Global Delta-Valerolactone Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Delta-Valerolactone Sales Estimates and Forecasts 2020-2031
2.4 Global Delta-Valerolactone Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Delta-Valerolactone Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
3.4.5 India
4 Competition by Manufacturers
4.1 Global Delta-Valerolactone Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Delta-Valerolactone Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 99% Market Size by Manufacturers
4.5.2 Purity 98% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Delta-Valerolactone Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Delta-Valerolactone Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Delta-Valerolactone Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Delta-Valerolactone Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Delta-Valerolactone Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Delta-Valerolactone Sales and Revenue by Type (2020-2031)
7.4 North America Delta-Valerolactone Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Delta-Valerolactone Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Delta-Valerolactone Sales and Revenue by Type (2020-2031)
8.4 Europe Delta-Valerolactone Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Delta-Valerolactone Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Delta-Valerolactone Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Delta-Valerolactone Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Delta-Valerolactone Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Delta-Valerolactone Sales and Revenue by Type (2020-2031)
10.4 Central and South America Delta-Valerolactone Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Delta-Valerolactone Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Delta-Valerolactone Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Delta-Valerolactone Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Delta-Valerolactone Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Business Overview
12.1.3 BASF Delta-Valerolactone Product Models, Descriptions and Specifications
12.1.4 BASF Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 BASF Delta-Valerolactone Sales by Product in 2024
12.1.6 BASF Delta-Valerolactone Sales by Application in 2024
12.1.7 BASF Delta-Valerolactone Sales by Geographic Area in 2024
12.1.8 BASF Delta-Valerolactone SWOT Analysis
12.1.9 BASF Recent Developments
12.2 UBE Industries
12.2.1 UBE Industries Corporation Information
12.2.2 UBE Industries Business Overview
12.2.3 UBE Industries Delta-Valerolactone Product Models, Descriptions and Specifications
12.2.4 UBE Industries Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 UBE Industries Delta-Valerolactone Sales by Product in 2024
12.2.6 UBE Industries Delta-Valerolactone Sales by Application in 2024
12.2.7 UBE Industries Delta-Valerolactone Sales by Geographic Area in 2024
12.2.8 UBE Industries Delta-Valerolactone SWOT Analysis
12.2.9 UBE Industries Recent Developments
12.3 CU Chemie Uetikon GmbH
12.3.1 CU Chemie Uetikon GmbH Corporation Information
12.3.2 CU Chemie Uetikon GmbH Business Overview
12.3.3 CU Chemie Uetikon GmbH Delta-Valerolactone Product Models, Descriptions and Specifications
12.3.4 CU Chemie Uetikon GmbH Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 CU Chemie Uetikon GmbH Delta-Valerolactone Sales by Product in 2024
12.3.6 CU Chemie Uetikon GmbH Delta-Valerolactone Sales by Application in 2024
12.3.7 CU Chemie Uetikon GmbH Delta-Valerolactone Sales by Geographic Area in 2024
12.3.8 CU Chemie Uetikon GmbH Delta-Valerolactone SWOT Analysis
12.3.9 CU Chemie Uetikon GmbH Recent Developments
12.4 Synova Chemicals
12.4.1 Synova Chemicals Corporation Information
12.4.2 Synova Chemicals Business Overview
12.4.3 Synova Chemicals Delta-Valerolactone Product Models, Descriptions and Specifications
12.4.4 Synova Chemicals Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Synova Chemicals Delta-Valerolactone Sales by Product in 2024
12.4.6 Synova Chemicals Delta-Valerolactone Sales by Application in 2024
12.4.7 Synova Chemicals Delta-Valerolactone Sales by Geographic Area in 2024
12.4.8 Synova Chemicals Delta-Valerolactone SWOT Analysis
12.4.9 Synova Chemicals Recent Developments
12.5 Aether Industries
12.5.1 Aether Industries Corporation Information
12.5.2 Aether Industries Business Overview
12.5.3 Aether Industries Delta-Valerolactone Product Models, Descriptions and Specifications
12.5.4 Aether Industries Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Aether Industries Delta-Valerolactone Sales by Product in 2024
12.5.6 Aether Industries Delta-Valerolactone Sales by Application in 2024
12.5.7 Aether Industries Delta-Valerolactone Sales by Geographic Area in 2024
12.5.8 Aether Industries Delta-Valerolactone SWOT Analysis
12.5.9 Aether Industries Recent Developments
12.6 NEM
12.6.1 NEM Corporation Information
12.6.2 NEM Business Overview
12.6.3 NEM Delta-Valerolactone Product Models, Descriptions and Specifications
12.6.4 NEM Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 NEM Recent Developments
12.7 Zhejiang Boadge Chemical
12.7.1 Zhejiang Boadge Chemical Corporation Information
12.7.2 Zhejiang Boadge Chemical Business Overview
12.7.3 Zhejiang Boadge Chemical Delta-Valerolactone Product Models, Descriptions and Specifications
12.7.4 Zhejiang Boadge Chemical Delta-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Zhejiang Boadge Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Delta-Valerolactone Industry Chain
13.2 Delta-Valerolactone Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Delta-Valerolactone Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Delta-Valerolactone Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Delta-Valerolactone Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Delta-Valerolactone Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
CU CHEMIE UETIKON GMBH
Synova Chemicals
Aether Industries
Nem
ZHEJIANG BOADGE CHEMICAL
List of Tables
 Table 1. Global Delta-Valerolactone Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Delta-Valerolactone Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Delta-Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Delta-Valerolactone Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Delta-Valerolactone Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Delta-Valerolactone Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Delta-Valerolactone Sales by Region (2020-2025) & (Tons)
 Table 8. Global Delta-Valerolactone Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Delta-Valerolactone Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Delta-Valerolactone Production by Region (2020-2025) & (Tons)
 Table 12. Global Delta-Valerolactone Production by Region (2026-2031) & (Tons)
 Table 13. Global Delta-Valerolactone Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Delta-Valerolactone Sales Share by Manufacturers (2020-2025)
 Table 15. Global Delta-Valerolactone Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Delta-Valerolactone Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Delta-Valerolactone by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Delta-Valerolactone as of 2024)
 Table 19. Global Delta-Valerolactone Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Delta-Valerolactone Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Delta-Valerolactone Manufacturing Base and Headquarters
 Table 22. Global Delta-Valerolactone Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Delta-Valerolactone Sales by Type (2020-2025) & (Tons)
 Table 26. Global Delta-Valerolactone Sales by Type (2026-2031) & (Tons)
 Table 27. Global Delta-Valerolactone Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Delta-Valerolactone Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Delta-Valerolactone ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Delta-Valerolactone Sales by Application (2020-2025) & (Tons)
 Table 32. Global Delta-Valerolactone Sales by Application (2026-2031) & (Tons)
 Table 33. Delta-Valerolactone High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Delta-Valerolactone Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Delta-Valerolactone Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Delta-Valerolactone ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Delta-Valerolactone Growth Accelerators and Market Barriers
 Table 40. North America Delta-Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Delta-Valerolactone Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Delta-Valerolactone Growth Accelerators and Market Barriers
 Table 43. Europe Delta-Valerolactone Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Delta-Valerolactone Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Delta-Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Delta-Valerolactone Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Delta-Valerolactone Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Delta-Valerolactone Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Delta-Valerolactone Investment Opportunities and Key Challenges
 Table 50. Central and South America Delta-Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Delta-Valerolactone Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Delta-Valerolactone Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. BASF Corporation Information
 Table 54. BASF Description and Major Businesses
 Table 55. BASF Product Models, Descriptions and Specifications
 Table 56. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. BASF Sales Value Proportion by Product in 2024
 Table 58. BASF Sales Value Proportion by Application in 2024
 Table 59. BASF Sales Value Proportion by Geographic Area in 2024
 Table 60. BASF Delta-Valerolactone SWOT Analysis
 Table 61. BASF Recent Developments
 Table 62. UBE Industries Corporation Information
 Table 63. UBE Industries Description and Major Businesses
 Table 64. UBE Industries Product Models, Descriptions and Specifications
 Table 65. UBE Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. UBE Industries Sales Value Proportion by Product in 2024
 Table 67. UBE Industries Sales Value Proportion by Application in 2024
 Table 68. UBE Industries Sales Value Proportion by Geographic Area in 2024
 Table 69. UBE Industries Delta-Valerolactone SWOT Analysis
 Table 70. UBE Industries Recent Developments
 Table 71. CU Chemie Uetikon GmbH Corporation Information
 Table 72. CU Chemie Uetikon GmbH Description and Major Businesses
 Table 73. CU Chemie Uetikon GmbH Product Models, Descriptions and Specifications
 Table 74. CU Chemie Uetikon GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. CU Chemie Uetikon GmbH Sales Value Proportion by Product in 2024
 Table 76. CU Chemie Uetikon GmbH Sales Value Proportion by Application in 2024
 Table 77. CU Chemie Uetikon GmbH Sales Value Proportion by Geographic Area in 2024
 Table 78. CU Chemie Uetikon GmbH Delta-Valerolactone SWOT Analysis
 Table 79. CU Chemie Uetikon GmbH Recent Developments
 Table 80. Synova Chemicals Corporation Information
 Table 81. Synova Chemicals Description and Major Businesses
 Table 82. Synova Chemicals Product Models, Descriptions and Specifications
 Table 83. Synova Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Synova Chemicals Sales Value Proportion by Product in 2024
 Table 85. Synova Chemicals Sales Value Proportion by Application in 2024
 Table 86. Synova Chemicals Sales Value Proportion by Geographic Area in 2024
 Table 87. Synova Chemicals Delta-Valerolactone SWOT Analysis
 Table 88. Synova Chemicals Recent Developments
 Table 89. Aether Industries Corporation Information
 Table 90. Aether Industries Description and Major Businesses
 Table 91. Aether Industries Product Models, Descriptions and Specifications
 Table 92. Aether Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Aether Industries Sales Value Proportion by Product in 2024
 Table 94. Aether Industries Sales Value Proportion by Application in 2024
 Table 95. Aether Industries Sales Value Proportion by Geographic Area in 2024
 Table 96. Aether Industries Delta-Valerolactone SWOT Analysis
 Table 97. Aether Industries Recent Developments
 Table 98. NEM Corporation Information
 Table 99. NEM Description and Major Businesses
 Table 100. NEM Product Models, Descriptions and Specifications
 Table 101. NEM Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. NEM Recent Developments
 Table 103. Zhejiang Boadge Chemical Corporation Information
 Table 104. Zhejiang Boadge Chemical Description and Major Businesses
 Table 105. Zhejiang Boadge Chemical Product Models, Descriptions and Specifications
 Table 106. Zhejiang Boadge Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Zhejiang Boadge Chemical Recent Developments
 Table 108. Key Raw Materials Distribution
 Table 109. Raw Materials Key Suppliers
 Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 111. Milestones in Production Technology Evolution
 Table 112. Distributors List
 Table 113. Market Trends and Market Evolution
 Table 114. Market Drivers and Opportunities
 Table 115. Market Challenges, Risks, and Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Delta-Valerolactone Product Picture
 Figure 2. Global Delta-Valerolactone Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity 99% Product Picture
 Figure 4. Purity 98% Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Delta-Valerolactone Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pharmaceutical
 Figure 8. Pesticide
 Figure 9. Fiber
 Figure 10. Others
 Figure 11. Delta-Valerolactone Report Years Considered
 Figure 12. Global Delta-Valerolactone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Delta-Valerolactone Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Delta-Valerolactone Revenue Market Share by Region (2020-2031)
 Figure 16. Global Delta-Valerolactone Sales (2020-2031) & (Tons)
 Figure 17. Global Delta-Valerolactone Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 18. Global Delta-Valerolactone Sales Market Share by Region (2020-2031)
 Figure 19. Global Delta-Valerolactone Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 20. Global Delta-Valerolactone Production Trend by Region (2020-2031) (Tons)
 Figure 21. Global Delta-Valerolactone Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. Delta-Valerolactone Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 24. Delta-Valerolactone Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 25. Delta-Valerolactone Production Growth Rate in China (2020-2031) & (Tons)
 Figure 26. Delta-Valerolactone Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 27. Delta-Valerolactone Production Growth Rate in India (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers Delta-Valerolactone Sales Volume Market Share in 2024
 Figure 29. Global Delta-Valerolactone Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Purity 99% Revenue Market Share by Manufacturer in 2024
 Figure 32. Purity 98% Revenue Market Share by Manufacturer in 2024
 Figure 33. Others Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 36. Global Delta-Valerolactone Sales Market Share by Type (2020-2031)
 Figure 37. Global Delta-Valerolactone Revenue Market Share by Type (2020-2031)
 Figure 38. Global Delta-Valerolactone Sales Market Share by Application (2020-2031)
 Figure 39. Global Delta-Valerolactone Revenue Market Share by Application (2020-2031)
 Figure 40. North America Delta-Valerolactone Sales YoY (2020-2031) & (Tons)
 Figure 41. North America Delta-Valerolactone Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. North America Top 5 Manufacturers Delta-Valerolactone Sales Revenue (US$ Million) in 2024
 Figure 43. North America Delta-Valerolactone Sales Volume (Tons) by Type (2020- 2031)
 Figure 44. North America Delta-Valerolactone Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 45. North America Delta-Valerolactone Sales Volume (Tons) by Application (2020-2031)
 Figure 46. North America Delta-Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. US Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 49. Mexico Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe Delta-Valerolactone Sales YoY (2020-2031) & (Tons)
 Figure 51. Europe Delta-Valerolactone Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Europe Top 5 Manufacturers Delta-Valerolactone Sales Revenue (US$ Million) in 2024
 Figure 53. Europe Delta-Valerolactone Sales Volume (Tons) by Type (2020-2031)
 Figure 54. Europe Delta-Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Europe Delta-Valerolactone Sales Volume (Tons) by Application (2020-2031)
 Figure 56. Europe Delta-Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Germany Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 58. France Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 59. U.K. Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 60. Italy Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 61. Russia Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Delta-Valerolactone Sales YoY (2020-2031) & (Tons)
 Figure 63. Asia-Pacific Delta-Valerolactone Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Asia-Pacific Top 8 Manufacturers Delta-Valerolactone Sales Revenue (US$ Million) in 2024
 Figure 65. Asia-Pacific Delta-Valerolactone Sales Volume (Tons) by Type (2020- 2031)
 Figure 66. Asia-Pacific Delta-Valerolactone Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 67. Asia-Pacific Delta-Valerolactone Sales Volume (Tons) by Application (2020-2031)
 Figure 68. Asia-Pacific Delta-Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Indonesia Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 70. Japan Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 73. India Delta-Valerolactone Revenue (2020-2031) & (US$ Million)
 Figure 74. Central and South America Delta-Valerolactone Sales YoY (2020-2031) & (Tons)
 Figure 75. Central and South America Delta-Valerolactone Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Central and South America Top 5 Manufacturers Delta-Valerolactone Sales Revenue (US$ Million) in 2024
 Figure 77. Central and South America Delta-Valerolactone Sales Volume (Tons) by Type (2021-2031)
 Figure 78. Central and South America Delta-Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Central and South America Delta-Valerolactone Sales Volume (Tons) by Application (2020-2031)
 Figure 80. Central and South America Delta-Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. Brazil Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 82. Argentina Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 83. Middle East, and Africa Delta-Valerolactone Sales YoY (2020-2031) & (Tons)
 Figure 84. Middle East and Africa Delta-Valerolactone Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Middle East and Africa Top 5 Manufacturers Delta-Valerolactone Sales Revenue (US$ Million) in 2024
 Figure 86. Middle East and Africa Delta-Valerolactone Sales Volume (Tons) by Type (2021-2031)
 Figure 87. South America Delta-Valerolactone Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Middle East and Africa Delta-Valerolactone Sales Volume (Tons) by Application (2020-2031)
 Figure 89. Middle East and Africa Delta-Valerolactone Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. GCC Countries Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 91. Turkey Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 92. Egypt Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 93. South Africa Delta-Valerolactone Revenue (2020-2025) & (US$ Million)
 Figure 94. Delta-Valerolactone Industry Chain Mapping
 Figure 95. Regional Delta-Valerolactone Manufacturing Base Distribution (%)
 Figure 96. Delta-Valerolactone Production Process
 Figure 97. Regional Delta-Valerolactone Production Cost Structure
 Figure 98. Channels of Distribution (Direct Vs Distribution)
 Figure 99. Bottom-up and Top-down Approaches for This Report
 Figure 100. Data Triangulation
 Figure 101. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Delta Dodecalactone Market Research Report 2024
Global γ valerolactone Market Research Report 2024
Global Gamma Valerolactone Market Research Report 2025
Global Valeryl Chloride Market Research Report 2024
Global Sitolactone Market Research Report 2024
Global Delta Lactones Market Research Report 2025
Global 2 4 Dichloroacetophenone Market Research Report 2024
Global Beta Propiolactone CAS 57 57 8 Market Research Report 2024
Global Delta Hexalactone Market Research Report 2025
Global δ Nonanoic Lactone Market Research Report 2024
Global Nitrilotriacetic Acid Market Research Report 2024
Global Delta Lactone Fragrance Market Research Report 2025
Global Sodium Perchlorate Market Research Report 2024
Global Beta Phellandrene Market Research Report 2024
Global Synthetic γ Octanolactone Market Research Report 2024
Global Disodium NADH Market Research Report 2024
Global Caprolactone Market Research Report 2025
Global 2 Ethyl 2 hydroxymethyl hexanoic Acid Market Research Report 2024
2 Butyl 2 ethyl 1 3 propanediol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alpha Phellandrene Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions